XML 235 R178.htm IDEA: XBRL DOCUMENT v3.25.0.1
Provisions, income tax liabilities and other liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Details) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of defined benefit plans [line items]      
Cost of sales € 13,205 € 12,628 [1] € 11,882 [1]
Research and development expenses 7,394 6,507 [1] 6,501 [1]
Selling and general expenses 9,183 8,933 [1] 8,739 [1]
Other operating (income)/expenses, net 3,789 2,979 1,231
Financial expenses 1,073 1,293 [1],[2],[3] 430 [1],[2],[3],[4]
Net income excluding the exchanged/held-for-exchange Animal Health business 64 338 [1] 401 [1]
Pensions and other post-employment benefits      
Disclosure of defined benefit plans [line items]      
Cost of sales 32 33 53
Research and development expenses 17 28 51
Selling and general expenses 42 57 78
Other operating (income)/expenses, net 4 5 (2)
Restructuring costs (64) (9) (59)
Financial expenses 60 67 42
Net income excluding the exchanged/held-for-exchange Animal Health business 9 9 5
Total € 100 € 190 € 168
[1] Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation
[2] (a)Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued
operation.
[3] (a)Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued
operation.
[4] 2022 business operating income has been recast from the amount previously reported to include the one-time income of €952 million from the Libtayo transaction (€706 million net of tax)